NASDAQ:PLUR Pluri (PLUR) Stock Price, News & Analysis → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free PLUR Stock Alerts $0.88 -0.14 (-13.73%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.85▼$0.9850-Day Range$0.57▼$1.0252-Week Range$0.43▼$1.07Volume458,047 shsAverage Volume111,050 shsMarket Capitalization$36.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Pluri alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Pluri Stock (NASDAQ:PLUR)Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.Read More PLUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PLUR Stock News HeadlinesMarch 28, 2024 | americanbankingnews.comPluri Stock to Reverse Split on Monday, April 1st (NASDAQ:PLUR)March 27, 2024 | globenewswire.comPluri Inc. Announces 1-for-8 Reverse Share SplitMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 21, 2024 | globenewswire.comPluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportMarch 19, 2024 | globenewswire.comEngage with Pluri's Talent: Exciting Conference Appearances AheadMarch 14, 2024 | globenewswire.comPluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingMarch 11, 2024 | globenewswire.comPluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationMarch 6, 2024 | globenewswire.comPluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 28, 2024 | finance.yahoo.comPluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsFebruary 28, 2024 | globenewswire.comPluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsFebruary 22, 2024 | msn.comStelmine Secures Minuapan for Further ExplorationFebruary 21, 2024 | msn.comGiant Strides Of Isa Kutepa’s Waltersmith PetromanFebruary 21, 2024 | finance.yahoo.comStelmine increases significantly the length of the gold-bearing corridor at MercatorFebruary 15, 2024 | finance.yahoo.comMeatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food TechnologyFebruary 14, 2024 | finance.yahoo.comPluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)January 25, 2024 | msn.comIsrael’s cell-based coffee: Sustainable solution to brewing industry challenges?January 23, 2024 | finance.yahoo.comStep into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisJanuary 10, 2024 | finanznachrichten.dePluri Inc.: Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing OrganizationJanuary 8, 2024 | finance.yahoo.comPluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing OrganizationDecember 21, 2023 | finance.yahoo.comPluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine AddictionDecember 14, 2023 | msn.comHow football became popular in BrazilDecember 4, 2023 | benzinga.comHealthEdge Partners with P3 Oral Surgery to Build Leading Oral Surgery PlatformNovember 28, 2023 | investing.comPluri Inc (PLUR) Earnings Dates & ReportsNovember 23, 2023 | morningstar.comPluri Inc PLURSeptember 19, 2023 | forbes.comFollowing USDA Approval Of Cultured Meat For Human Consumption, Race Is On To Manufacture Product At ScaleSeptember 14, 2023 | finance.yahoo.comPluri Full Year 2023 Earnings: US$0.77 loss per share (vs US$1.28 loss in FY 2022)See More Headlines Receive PLUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/12/2024Today3/27/2024Next Earnings (Estimated)5/14/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:PLUR CUSIPN/A CIK1158780 Webpluri-biotech.com Phone972747108600Fax972-74-710-8787Employees123Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,320,000.00 Net Margins-6,708.40% Pretax Margin-6,850.42% Return on Equity-177.94% Return on Assets-49.60% Debt Debt-to-Equity Ratio3.69 Current Ratio7.12 Quick Ratio7.12 Sales & Book Value Annual Sales$290,000.00 Price / Sales125.84 Cash FlowN/A Price / Cash FlowN/A Book Value$0.37 per share Price / Book2.38Miscellaneous Outstanding Shares41,480,000Free Float31,400,000Market Cap$36.49 million OptionableOptionable Beta1.45 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Yaacov Yanay (Age 53)President, CEO & Director Comp: $575.93kMs. Chen Franco-Yehuda (Age 41)CFO, Treasurer & Secretary Comp: $375.24kMr. Lior RavivChief Technology OfficerMs. Efrat Livne-HadassVice President of Human ResourcesDr. Nitsan Halevy M.D.Chief Medical OfficerMr. Nimrod Bar ZviChief Commercial OfficerMore ExecutivesKey CompetitorsNKGen BiotechNYSE:NKGNOKYO PharmaNASDAQ:OKYOCandel TherapeuticsNASDAQ:CADLCyclo TherapeuticsNASDAQ:CYTHCASI PharmaceuticalsNASDAQ:CASIView All CompetitorsInstitutional OwnershipCitadel Advisors LLCBought 32,279 shares on 2/15/2024Ownership: 0.139%View All Institutional Transactions PLUR Stock Analysis - Frequently Asked Questions How have PLUR shares performed in 2024? Pluri's stock was trading at $0.5795 at the start of the year. Since then, PLUR shares have increased by 51.8% and is now trading at $0.8798. View the best growth stocks for 2024 here. Are investors shorting Pluri? Pluri saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 163,900 shares, a decrease of 16.7% from the February 29th total of 196,800 shares. Based on an average daily trading volume, of 112,800 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.5% of the company's stock are sold short. View Pluri's Short Interest. When is Pluri's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our PLUR earnings forecast. How were Pluri's earnings last quarter? Pluri Inc. (NASDAQ:PLUR) announced its earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter. The business earned $0.11 million during the quarter. Pluri had a negative net margin of 6,708.40% and a negative trailing twelve-month return on equity of 177.94%. When did Pluri's stock split? Pluri shares reverse split before market open on Monday, April 1st 2024. The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. Who are Pluri's major shareholders? Pluri's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Citadel Advisors LLC (0.14%) and Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Pluri? Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PLUR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.